Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA
Search results for: inhibitor
Bariatric Surgery May Help Obese Patients with Gout, Diabetes
Researchers found patients with morbid obesity, gout and diabetes achieved target serum urate concentrations post-bariatric surgery
Is Shared Decision Making Possible in Rheumatology?
A rheumatologist voices skepticism that physicians, patients can arrive at mutually shared healthcare decisions
Walking Aids in Assessment of Rheumatology Patients
Rheumatologists can gain insight into patients’ state of health by watching them walk
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
Rheumatologists May Help Patients with Rheumatoid Arthritis Overcome Obstacles to Sex
By asking about their sexual relationships, rheumatologists can improve quality of patients’ love lives
What’s New in Inflammatory Arthritis?
Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair
New Osteoporosis Drugs Show Promise in Therapy Pipeline
Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options
Why Tweaking Molecular Structures Can Be Hazardous to Our Health
The rise and fall of rofecoxib and valdecoxib demonstrate the need for caution in new drug development
New Treatments Needed to Prevent Fractures in Osteoporosis
Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact
- « Previous Page
- 1
- …
- 89
- 90
- 91
- 92
- 93
- …
- 110
- Next Page »